Related Experiment Video

Updated: May 15, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

2-Hydroxycinnamaldehyde inhibits the epithelial-mesenchymal transition in breast cancer cells

Ismail Ahmed Ismail1, Hye Sook Kang, Heon-Jin Lee

  • 1Department of Oral Microbiology, School of Dentistry, Kyungpook National University, Daegu, Republic of Korea.

Breast Cancer Research and Treatment
|January 4, 2013
PubMed

Insights

The natural compound 2'-Hydroxycinnamaldehyde (HCA) effectively inhibits breast cancer metastasis by reversing epithelial-mesenchymal transition (EMT). HCA targets key molecular pathways, offering a promising non-toxic therapeutic strategy for advanced cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Epithelial-mesenchymal transition (EMT) is crucial for cancer progression and metastasis.
  • EMT is a key target for anti-cancer therapies aiming to inhibit cancer spread.
  • 2'-Hydroxycinnamaldehyde (HCA) shows potential as a therapeutic agent for cancer treatment.

Purpose of the Study:

  • To investigate the anti-metastatic effects of HCA on breast cancer.
  • To elucidate the molecular mechanisms by which HCA regulates EMT.
  • To evaluate HCA's impact on the transcriptional program during EMT.

Main Methods:

  • Investigated HCA's effect on EMT markers in breast cancer cells.
  • Analyzed the role of GSK-3β and Snail in HCA-mediated epithelial reversion.
  • Assessed the activation of KLF17 and suppression of Id-1 by HCA.
  • Evaluated HCA's efficacy in inhibiting lung metastasis in a mouse orthotopic breast cancer model.

Main Results:

  • HCA induced epithelial reversion at nanomolar concentrations by suppressing Snail via GSK-3β nuclear translocation.
  • HCA treatment led to the transcriptional upregulation of E-cadherin.
  • HCA activated KLF17, which suppressed Id-1, indicating multi-pathway inhibition of EMT.
  • HCA significantly inhibited lung metastasis in vivo.

Conclusions:

  • HCA demonstrates significant anti-metastatic effects in breast cancer by attenuating EMT.
  • HCA acts through multiple transcriptional programs to inhibit EMT, including Snail suppression and KLF17 activation.
  • HCA is a non-toxic natural compound with therapeutic potential for inhibiting cancer metastasis.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...